Researchers from The University of Queensland & Mater Research will present their findings alongside Microba’s Dr David Wood in a webinar on ex...
We are innovating to help humanity achieve some of its most inspiring medical advancements in the 21st century. Read about Microba’s progress, partnership news and latest discoveries.
Leading Australian universities will explore the ‘cognobiome’ of soldiers using Microba’s analysis platform to discover opportunities for improving...
Results published in Cell show dietary restriction drives microbiome diversity changes in autistic individuals.
Dr Jean-Philippe Laine joins as US Director of Business Development to drive forward global research and discovery partnerships.
Microba will work with Anatara to complete microbiome analysis for a much-needed therapeutic treatment for sufferers of IBS-D.
Experts will present opportunities for harnessing the microbiome for innovative products, therapies and diagnostics to a global audience.
Using the NEW1000 Family Study, researchers will investigate the role of the microbiome in the developmental origins of health and disease.
Dr David Wood will present at the Microbiome Data Congress to discuss the importance of precise gut microbiome profiling for biomarker discovery.
Microba Life Sciences has united with Illumina, Inc. to advance understanding of the human gut microbiome in human health and disease.